Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 383

1.

Real-time contrast-enhanced transrectal US-guided prostate biopsy: diagnostic accuracy in men with previously negative biopsy results and positive MR imaging findings.

Cornelis F, Rigou G, Le Bras Y, Coutouly X, Hubrecht R, Yacoub M, Pasticier G, Robert G, Grenier N.

Radiology. 2013 Oct;269(1):159-66. doi: 10.1148/radiol.13122393. Epub 2013 May 8.

PMID:
23657887
2.

[Real-time MRI/US fusion-guided biopsy improves detection rates of prostate cancer in pre-biopsied patients].

Maxeiner A, Fischer T, Stephan C, Cash H, Slowinski T, Kilic E, Durmus T.

Aktuelle Urol. 2014 May;45(3):197-203. doi: 10.1055/s-0034-1375682. Epub 2014 Jun 5. German.

PMID:
24902069
3.

Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies.

Pokorny MR, de Rooij M, Duncan E, Schröder FH, Parkinson R, Barentsz JO, Thompson LC.

Eur Urol. 2014 Jul;66(1):22-9. doi: 10.1016/j.eururo.2014.03.002. Epub 2014 Mar 14.

PMID:
24666839
4.

Prospective randomized trial comparing magnetic resonance imaging (MRI)-guided in-bore biopsy to MRI-ultrasound fusion and transrectal ultrasound-guided prostate biopsy in patients with prior negative biopsies.

Arsov C, Rabenalt R, Blondin D, Quentin M, Hiester A, Godehardt E, Gabbert HE, Becker N, Antoch G, Albers P, Schimmöller L.

Eur Urol. 2015 Oct;68(4):713-20. doi: 10.1016/j.eururo.2015.06.008. Epub 2015 Jun 23.

PMID:
26116294
5.

Prostate cancer diagnosis: multiparametric MR-targeted biopsy with cognitive and transrectal US-MR fusion guidance versus systematic biopsy--prospective multicenter study.

Puech P, Rouvière O, Renard-Penna R, Villers A, Devos P, Colombel M, Bitker MO, Leroy X, Mège-Lechevallier F, Comperat E, Ouzzane A, Lemaitre L.

Radiology. 2013 Aug;268(2):461-9. doi: 10.1148/radiol.13121501. Epub 2013 Apr 11.

PMID:
23579051
6.

Prebiopsy Multiparametric Magnetic Resonance Imaging for Prostate Cancer Diagnosis in Biopsy-naive Men with Suspected Prostate Cancer Based on Elevated Prostate-specific Antigen Values: Results from a Randomized Prospective Blinded Controlled Trial.

Tonttila PP, Lantto J, Pääkkö E, Piippo U, Kauppila S, Lammentausta E, Ohtonen P, Vaarala MH.

Eur Urol. 2016 Mar;69(3):419-25. doi: 10.1016/j.eururo.2015.05.024. Epub 2015 May 29.

PMID:
26033153
7.

Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer.

Kuru TH, Roethke MC, Seidenader J, Simpfendörfer T, Boxler S, Alammar K, Rieker P, Popeneciu VI, Roth W, Pahernik S, Schlemmer HP, Hohenfellner M, Hadaschik BA.

J Urol. 2013 Oct;190(4):1380-6. doi: 10.1016/j.juro.2013.04.043. Epub 2013 Apr 19.

PMID:
23608676
8.

[Value of perineal HistoScanning™ template-guided prostate biopsy].

Hamann MF, Hamann C, Olzem D, Trettel A, Juenemann KP, Naumann CM.

Urologe A. 2015 Nov;54(11):1596, 1598-601. doi: 10.1007/s00120-014-3731-x. German.

PMID:
25794587
9.

Multiparametric magnetic resonance imaging of the prostate can improve the predictive value of the urinary prostate cancer antigen 3 test in patients with elevated prostate-specific antigen levels and a previous negative biopsy.

Sciarra A, Panebianco V, Cattarino S, Busetto GM, De Berardinis E, Ciccariello M, Gentile V, Salciccia S.

BJU Int. 2012 Dec;110(11):1661-5. doi: 10.1111/j.1464-410X.2012.11146.x. Epub 2012 May 4.

10.

Multiparametric magnetic resonance imaging (MRI) and subsequent MRI/ultrasonography fusion-guided biopsy increase the detection of anteriorly located prostate cancers.

Volkin D, Turkbey B, Hoang AN, Rais-Bahrami S, Yerram N, Walton-Diaz A, Nix JW, Wood BJ, Choyke PL, Pinto PA.

BJU Int. 2014 Dec;114(6b):E43-E49. doi: 10.1111/bju.12670. Epub 2014 Oct 18.

11.

[Detection of prostate cancer by real-time MR/ultrasound fusion-guided biopsy: 3T MRI and state of the art sonography].

Durmus T, Stephan C, Grigoryev M, Diederichs G, Saleh M, Slowinski T, Maxeiner A, Thomas A, Fischer T.

Rofo. 2013 May;185(5):428-33. doi: 10.1055/s-0032-1330704. Epub 2013 Feb 18. German.

12.

The value and limitations of contrast-enhanced transrectal ultrasonography for the detection of prostate cancer.

Zhao HX, Xia CX, Yin HX, Guo N, Zhu Q.

Eur J Radiol. 2013 Nov;82(11):e641-7. doi: 10.1016/j.ejrad.2013.07.004. Epub 2013 Aug 3.

PMID:
23916578
13.

Three-Tesla magnetic resonance-guided prostate biopsy in men with increased prostate-specific antigen and repeated, negative, random, systematic, transrectal ultrasound biopsies: detection of clinically significant prostate cancers.

Hoeks CM, Schouten MG, Bomers JG, Hoogendoorn SP, Hulsbergen-van de Kaa CA, Hambrock T, Vergunst H, Sedelaar JP, Fütterer JJ, Barentsz JO.

Eur Urol. 2012 Nov;62(5):902-9. doi: 10.1016/j.eururo.2012.01.047. Epub 2012 Feb 1.

PMID:
22325447
14.

Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen.

Hambrock T, Somford DM, Hoeks C, Bouwense SA, Huisman H, Yakar D, van Oort IM, Witjes JA, Fütterer JJ, Barentsz JO.

J Urol. 2010 Feb;183(2):520-7. doi: 10.1016/j.juro.2009.10.022. Epub 2009 Dec 14.

PMID:
20006859
15.

[Real-time MRI/US fusion-guided biopsy in biopsy-naïve and pre-biopsied patients with suspicion for prostate cancer].

Maxeiner A, Stephan C, Fischer T, Durmus T, Kilic E, Asbach P, Haas M, Günzel K, Neymeyer J, Miller K, Cash H.

Aktuelle Urol. 2015 Jan;46(1):34-8. doi: 10.1055/s-0034-1395563. Epub 2014 Dec 17. German.

PMID:
25519051
16.

Diagnostic performance of power doppler and ultrasound contrast agents in early imaging-based diagnosis of organ-confined prostate cancer: Is it possible to spare cores with contrast-guided biopsy?

Delgado Oliva F, Arlandis Guzman S, Bonillo García M, Broseta Rico E, Boronat Tormo F.

Eur J Radiol. 2016 Oct;85(10):1778-1785. doi: 10.1016/j.ejrad.2016.07.021. Epub 2016 Aug 1.

PMID:
27666616
17.

Contrast-enhanced transrectal ultrasonography for the detection of diffuse prostate cancer.

Gao Y, Liao XH, Lu L, Wang L, Ma Y, Qin HZ, Yan X, Guo P.

Clin Radiol. 2016 Mar;71(3):258-64. doi: 10.1016/j.crad.2015.11.013. Epub 2015 Dec 28.

PMID:
26738964
18.

Multiparametric MRI guidance in first-time prostate biopsies: what is the real benefit?

Acar Ö, Esen T, Çolakoğlu B, Vural M, Onay A, Sağlıcan Y, Türkbey B, Rozanes İ.

Diagn Interv Radiol. 2015 Jul-Aug;21(4):271-6. doi: 10.5152/dir.2015.46014.

19.

Impact of real-time elastography on magnetic resonance imaging/ultrasound fusion guided biopsy in patients with prior negative prostate biopsies.

Brock M, Löppenberg B, Roghmann F, Pelzer A, Dickmann M, Becker W, Martin-Seidel P, Sommerer F, Schenk L, Palisaar RJ, Noldus J, von Bodman C.

J Urol. 2015 Apr;193(4):1191-7. doi: 10.1016/j.juro.2014.10.106. Epub 2014 Nov 4.

PMID:
25451832
20.

Abbreviated Biparametric Prostate MR Imaging in Men with Elevated Prostate-specific Antigen.

Kuhl CK, Bruhn R, Krämer N, Nebelung S, Heidenreich A, Schrading S.

Radiology. 2017 Jul 20:170129. doi: 10.1148/radiol.2017170129. [Epub ahead of print]

PMID:
28727544

Supplemental Content

Support Center